Edgewise Therapeutics
(NASDAQ) EWTX
Edgewise Therapeutics Financials at a Glance
Market Cap
$3.29B
Revenue (TTM)
$0.00
Net Income (TTM)
$167.79M
EPS (TTM)
$-1.63
P/E Ratio
-18.77
Dividend
$0.00
Beta (Volatility)
1.47 (Average)
Dividend
$0.00
Beta (Volatility)
1.47 (Average)
Price
$31.93
Volume
30,790
Open
$31.19
Price
$31.93
Volume
30,790
Open
$31.19
Previous Close
$31.93
Daily Range
$31.19 - $32.79
52-Week Range
$10.60 - $32.79
Dividend
$0.00
Beta (Volatility)
1.47 (Average)
Price
$31.93
Volume
30,790
Open
$31.19
Previous Close
$31.93
Daily Range
$31.19 - $32.79
52-Week Range
$10.60 - $32.79
EWTX News
EWTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Edgewise Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
146
CEO
Kevin Koch, PhD
Website
www.edgewisetx.comHeadquarters
Boulder, CO 80303, US
EWTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-34%
Return on Capital
-36%
Return on Assets
-30%
Earnings Yield
-5.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.29B
Shares Outstanding
107.27M
Volume
30.79K
Short Interest
0.00%
Avg. Volume
1.02M
Financials (TTM)
Gross Profit
$2.27M
Operating Income
$191.41M
EBITDA
$165.53M
Operating Cash Flow
$143.82M
Capital Expenditure
$256.00K
Free Cash Flow
$143.82M
Cash & ST Invst.
$530.11M
Total Debt
$3.99M
Edgewise Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$3.29B
N/A
Market Cap/Employee
$28.09M
N/A
Employees
117
N/A
Net Income
$50.22M
-26.6%
EBITDA
$51.86M
-15.5%
Quarterly Fundamentals
Net Cash
$526.12M
+13.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$2.98M
-20.4%
Short Term Debt
$1.01M
+1.8%
Return on Assets
-30.36%
N/A
Return on Invested Capital
-36.44%
N/A
Free Cash Flow
$38.41M
-41.0%
Operating Cash Flow
$38.59M
-43.2%